ZOMDF
$0.11
(-5.67%)
FLWS
$3.28
(1.86%)
ACCO
$2.85
(-0.87%)
ARLP
$28.32
(0.55%)
AUIAF
$0.14
(0%)
AZZ
$127.43
(0.83%)
BTBT
$1.4
(1.82%)
BTM
$2.55
(18.06%)
CVKD
$4.49
(-4.57%)
LCE:CA
$0.38
(0%)
COCP
$1.4
(-7.28%)
CDRO
$8.55
(0.59%)
CVGI
$3.94
(10.81%)
LODE
$3.52
(-1.82%)
CMTL
$3.73
(5.07%)
CNDT
$1.42
(1.8%)
CXW
$20.21
(-1.44%)
CMLS
$0.01
(0%)
DRCT
$0.86
(13.02%)
DLHC
$5.58
(-1.06%)
SSP
$3.88
(6.44%)
ELDN
$3.15
(2.44%)
EVC
$3
(-0.66%)
EDRY
$19.79
(0.07%)
ESEA
$67.41
(0.19%)
FAT
$0.16
(0%)
RAIL
$8.37
(1.7%)
GDEV
$14.38
(-3.46%)
GOVX
$1.29
(-3.01%)
GOCO
$1.28
(0.39%)
GHM
$82.53
(1.58%)
GLDD
$0
(0%)
GYRE
$6.87
(1.33%)
HMENF
$1.99
(0.96%)
III
$3.95
(-0.25%)
IPOOF
$12.72
(0.63%)
KELYA
$8.82
(0.46%)
KTOS
$73.45
(9.12%)
LUCK
$8.7
(1.28%)
MAIA
$1.3
(-2.26%)
MGROF
$0.42
(9.78%)
NTRB
$3.57
(-1.77%)
OCGN
$1.79
(-0.01%)
PERF
$1.65
(-2.66%)
QMCI
$0.14
(0%)
RGP
$3.69
(0.14%)
SGA
$11.6
(-1.78%)
SHWZ
$0
(900%)
SHIP
$13.96
(-0.32%)
SLQT
$0.62
(1.7%)
SKYX
$1.16
(0.43%)
SNAL
$0.53
(2.94%)
GEO
$18.08
(-1.85%)
ODP
$28
(0%)
TNXP
$13.78
(-0.88%)
TSQ
$5.7
(-0.09%)
TZOO
$5.96
(1.02%)
UNCY
$6.79
(-2.02%)
VVX
$70.71
(1.38%)
VNCE
$2.37
(0%)
XELB
$1.56
(15.56%)
ZOMDF
$0.11
(-5.67%)
FLWS
$3.28
(1.86%)

4/6/2026

Neurocrine to Acquire Soleno Therapeutics, Expanding Rare Disease and Endocrinology Portfolio

The acquisition adds VYKAT™ XR (diazoxide choline), the first and only FDA-approved treatment for hyperphagia in Prader-Willi syndrome (PWS), to Neurocrine’s growing portfolio of first-in-class therapies.

0
4 min read

  • Noble Capital Markets Research Morning Call

    Noble Capital Markets Research Morning Call

    Today’s Noble Capital Markets equity research reports, available with free...

    144 min read
  • No Cuts, No Ceasefire, No Clarity: The Macro Wall Investors Are Staring Down

    3 min read
  • Receive FREE Research, News, Video, and Event Updates in Your Inbox!

  • The Pharma Tariff Playbook: How Drug Companies Can Navigate the Administration’s Latest Pricing Push

    3 min read

News

4/6/2026

Release – Townsquare Announces Conference Call to Discuss First Quarter 2026 Results

3 min read

Release – Townsquare Announces Conference Call to Discuss First Quarter 2026 Results
4/6/2026

Release – NeuroSense Granted Brazilian Patent Covering PrimeC Composition

5 min read

Release – NeuroSense Granted Brazilian Patent Covering PrimeC Composition
4/6/2026

Release – The Oncology Institute Names Minh Merchant Chief Legal Officer

2 min read

Release – The Oncology Institute Names Minh Merchant Chief Legal Officer
4/6/2026

Release – Snail Games Expands Portfolio with Publishing Agreement for Co-op Party Action Title Dead Party

4 min read

Release – Snail Games Expands Portfolio with Publishing Agreement for Co-op Party Action Title Dead Party

Video Content


  • ZenaTech Inc.

    ZenaTech Inc.

    Conference Presentation
    2/5/2026

  • VivoPower International PLC

    VivoPower International PLC

    Conference Presentation
    2/5/2026

  • IN8bio Inc.

    IN8bio Inc.

    Conference Presentation
    2/5/2026

  • Star Equity Holdings Inc.

    Star Equity Holdings Inc.

    Conference Presentation
    2/5/2026
  • Movers

    Symbol
    Change
    MAXN
    70.35%
    SMX
    66.84%
    MIGI
    46.53%
    CLIR
    40.99%
    RCMT
    36.48%